188 related articles for article (PubMed ID: 35053438)
21. Anti-colon cancer effect of caffeic acid p-nitro-phenethyl ester in vitro and in vivo and detection of its metabolites.
Tang H; Yao X; Yao C; Zhao X; Zuo H; Li Z
Sci Rep; 2017 Aug; 7(1):7599. PubMed ID: 28790461
[TBL] [Abstract][Full Text] [Related]
22. Actvation of NF-kappaB by the API2/MALT1 fusions inhibits p53 dependant but not FAS induced apoptosis: a directional link between NF-kappaB and p53.
Stoffel A; Levine AJ
Cell Cycle; 2004 Aug; 3(8):1017-20. PubMed ID: 15280657
[TBL] [Abstract][Full Text] [Related]
23. Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells.
Sanderson JT; Clabault H; Patton C; Lassalle-Claux G; Jean-François J; Paré AF; Hébert MJ; Surette ME; Touaibia M
Bioorg Med Chem; 2013 Nov; 21(22):7182-93. PubMed ID: 24080105
[TBL] [Abstract][Full Text] [Related]
24. Involvement of tumor suppressor protein p53 and p38 MAPK in caffeic acid phenethyl ester-induced apoptosis of C6 glioma cells.
Lee YJ; Kuo HC; Chu CY; Wang CJ; Lin WC; Tseng TH
Biochem Pharmacol; 2003 Dec; 66(12):2281-9. PubMed ID: 14637186
[TBL] [Abstract][Full Text] [Related]
25. Caffeic Acid phenethyl ester as a potential treatment for advanced prostate cancer targeting akt signaling.
Lin HP; Lin CY; Liu CC; Su LC; Huo C; Kuo YY; Tseng JC; Hsu JM; Chen CK; Chuu CP
Int J Mol Sci; 2013 Mar; 14(3):5264-83. PubMed ID: 23466879
[TBL] [Abstract][Full Text] [Related]
26. Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma.
Hosokawa Y
Apoptosis; 2005 Jan; 10(1):25-34. PubMed ID: 15711920
[TBL] [Abstract][Full Text] [Related]
27. The Upregulation of Caffeic Acid Phenethyl Ester on Growth Differentiation Factor 15 Inhibits Transforming Growth Factor β/Smad Signaling in Bladder Carcinoma Cells.
Hou CP; Tsui KH; Chen ST; Chang KS; Sung HC; Hsu SY; Lin YH; Feng TH; Juang HH
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884930
[TBL] [Abstract][Full Text] [Related]
28. A Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-kappaB activation by API2middle dotMALT1 fusions.
Noels H; van Loo G; Hagens S; Broeckx V; Beyaert R; Marynen P; Baens M
J Biol Chem; 2007 Apr; 282(14):10180-9. PubMed ID: 17287209
[TBL] [Abstract][Full Text] [Related]
29. API2-MALT1 oncoprotein promotes lymphomagenesis via unique program of substrate ubiquitination and proteolysis.
Rosebeck S; Lim MS; Elenitoba-Johnson KS; McAllister-Lucas LM; Lucas PC
World J Biol Chem; 2016 Feb; 7(1):128-37. PubMed ID: 26981201
[TBL] [Abstract][Full Text] [Related]
30. Caffeic acid phenethyl ester attenuates lipopolysaccharide-stimulated proinflammatory responses in human gingival fibroblasts via NF-κB and PI3K/Akt signaling pathway.
Li L; Sun W; Wu T; Lu R; Shi B
Eur J Pharmacol; 2017 Jan; 794():61-68. PubMed ID: 27832944
[TBL] [Abstract][Full Text] [Related]
31. Caffeic acid phenethyl ester promotes anti-inflammatory effects by inhibiting MAPK and NF-κB signaling in activated HMC-1 human mast cells.
Cho MS; Park WS; Jung WK; Qian ZJ; Lee DS; Choi JS; Lee DY; Park SG; Seo SK; Kim HJ; Won JY; Yu BC; Choi IW
Pharm Biol; 2014 Jul; 52(7):926-32. PubMed ID: 24920235
[TBL] [Abstract][Full Text] [Related]
32. Caffeic acid phenethyl ester inhibits nuclear factor-kappaB and protein kinase B signalling pathways and induces caspase-3 expression in primary human CD4+ T cells.
Wang LC; Chu KH; Liang YC; Lin YL; Chiang BL
Clin Exp Immunol; 2010 May; 160(2):223-32. PubMed ID: 20059479
[TBL] [Abstract][Full Text] [Related]
33. Alternative expression pattern of MALT1-A20-NF-κB in patients with rheumatoid arthritis.
Wang X; Zhu L; Liao Z; Zhang F; Xu L; Xu Y; Chen S; Yang L; Zhou Y; Li Y
J Immunol Res; 2014; 2014():492872. PubMed ID: 24971370
[TBL] [Abstract][Full Text] [Related]
34. [Impact of NF-kappaB inhibitor on STAT3 translocation in PC-3 prostate cancer cell line].
Li CY; Zhao HX; Zhang X; Chu L; Fang JM; Han H; Liu X; Xu Q
Zhonghua Nan Ke Xue; 2013 Jun; 19(6):487-94. PubMed ID: 23862224
[TBL] [Abstract][Full Text] [Related]
35. MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-κB and NLRP3 inflammasome activation.
Liu W; Guo W; Hang N; Yang Y; Wu X; Shen Y; Cao J; Sun Y; Xu Q
Oncotarget; 2016 May; 7(21):30536-49. PubMed ID: 27105502
[TBL] [Abstract][Full Text] [Related]
36. MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells.
Ho L; Davis RE; Conne B; Chappuis R; Berczy M; Mhawech P; Staudt LM; Schwaller J
Blood; 2005 Apr; 105(7):2891-9. PubMed ID: 15598810
[TBL] [Abstract][Full Text] [Related]
37. Cardioprotection of CAPE-oNO
Li D; Wang X; Huang Q; Li S; Zhou Y; Li Z
Redox Biol; 2018 May; 15():62-73. PubMed ID: 29220696
[TBL] [Abstract][Full Text] [Related]
38. Activation of neutral-sphingomyelinase, MAPKs, and p75 NTR-mediating caffeic acid phenethyl ester-induced apoptosis in C6 glioma cells.
Tseng TH; Shen CH; Huang WS; Chen CN; Liang WH; Lin TH; Kuo HC
J Biomed Sci; 2014 Jul; 21(1):61. PubMed ID: 24997497
[TBL] [Abstract][Full Text] [Related]
39. The effect of caffeic acid phenethyl ester on the functions of human monocyte-derived dendritic cells.
Wang LC; Lin YL; Liang YC; Yang YH; Lee JH; Yu HH; Wu WM; Chiang BL
BMC Immunol; 2009 Jul; 10():39. PubMed ID: 19604415
[TBL] [Abstract][Full Text] [Related]
40. Predictive role of nuclear factor-kappaB activity in gastric cancer: a promising adjuvant approach with caffeic acid phenethyl ester.
Wu CS; Chen MF; Lee IL; Tung SY
J Clin Gastroenterol; 2007; 41(10):894-900. PubMed ID: 18090157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
